tiprankstipranks
Trending News
More News >
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ:SHPH
US Market
Advertisement

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Price & Analysis

Compare
104 Followers

SHPH Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

12.68%1.02%0.84%86.30%
12.68% Insiders
0.84% Other Institutional Investors
86.30% Public Companies and
Individual Investors

SHPH FAQ

What was Shuttle Pharmaceuticals Holdings, Inc.’s price range in the past 12 months?
Shuttle Pharmaceuticals Holdings, Inc. lowest stock price was $3.00 and its highest was $97.60 in the past 12 months.
    What is Shuttle Pharmaceuticals Holdings, Inc.’s market cap?
    Shuttle Pharmaceuticals Holdings, Inc.’s market cap is $4.08M.
      When is Shuttle Pharmaceuticals Holdings, Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Shuttle Pharmaceuticals Holdings, Inc.’s earnings last quarter?
      Currently, no data Available
      Is Shuttle Pharmaceuticals Holdings, Inc. overvalued?
      According to Wall Street analysts Shuttle Pharmaceuticals Holdings, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Shuttle Pharmaceuticals Holdings, Inc. pay dividends?
        Shuttle Pharmaceuticals Holdings, Inc. does not currently pay dividends.
        What is Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate?
        Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Shuttle Pharmaceuticals Holdings, Inc. have?
        Shuttle Pharmaceuticals Holdings, Inc. has 1,070,325 shares outstanding.
          What happened to Shuttle Pharmaceuticals Holdings, Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Shuttle Pharmaceuticals Holdings, Inc.?
          Currently, no hedge funds are holding shares in SHPH

          Company Description

          Shuttle Pharmaceuticals Holdings, Inc.

          Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
          Similar Stocks
          Company
          Price & Change
          Follow
          Alaunos Therapeutics
          Scinai Immunotherapeutics
          InMed Pharmaceuticals
          Hyperion DeFi
          Revelation Biosciences
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis